Cancers | Free Full-Text | Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
Survival analysis and treatment. A. Progression Free Survival (PFS) and... | Download Scientific Diagram
Shows the progression-free survival (PFS) and overall survival (OS) by... | Download Scientific Diagram
Progression-free survival (PFS) and Overall survival (OS) for all 115 patients with follicular lymphoma according to the prognostic scoring system incorporating the 3 independent risk factors for both PFS and OS.
Progression free survival (PFS) and overall survival (OS) by NLR. A)... | Download Scientific Diagram
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials - ScienceDirect
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley